Modulation of the dendritic cell-T-cell synapse to promote pathogen immunity and prevent autoimmunity

Immunotherapy

Volumn 3, Issue 4 SUPPL., 2011, Pages 6-11

  Carreño, Leandro J ^a   González, Pablo A ^a   Bueno, Susan M ^a   Riedel, Claudia A ^a,b   Kalergis, Alexis M ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

autoimmunity; dendritic cells; immunological synapse; pMHC; T cells; TCR

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIBIOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING KINETICS; CELL FUNCTION; DENDRITIC CELL; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL SYNAPSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INTERFERENCE;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNOLOGICAL SYNAPSES; IMMUNOMODULATION; INFECTION; T-LYMPHOCYTES;

EID: 79955614515     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/imt.11.38     Document Type: Article

References (45)

1. Bueno SM, Gonzalez PA, Pacheco R et al.: Host immunity during RSV pathogenesis. Int. Immunopharmacol. 8(10), 1320-1329 (2008).
2. Carreno LJ, Gonzalez PA, Kalergis AM: Modulation of T cell function by TCR/ pMHC binding kinetics. Immunobiology 211(1-2), 47-64 (2006).
3. Gonzalez PA, Carreno LJ, Figueroa CA, Kalergis AM: Modulation of immunological synapse by membrane-bound and soluble ligands. Cytokine Growth Factor Rev. 18(1-2), 19-31 (2007).
4. Kalergis AM: Modulation of T cell immunity by TCR/pMHC dwell time and activating/ inhibitory receptor pairs on the antigen-presenting cell. Curr. Pharm. Des. 9(3), 233-244 (2003). (Pubitemid 36131717)
5. Chothia C, Boswell DR, Lesk AM: The outline structure of the T-cell a b receptor. EMBO J. 7(12), 3745-3755. (1988).
6. Van Der Merwe PA, Davis SJ: Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21, 659-684 (2003). (Pubitemid 37174544)
7. Apostolopoulos V, Lazoura E, Yu M: MHC and MHC-like molecules: structural perspectives on the design of molecular vaccines. Adv. Exp. Med. Biol. 640, 252-267 (2008).
8. Carreno LJ, Bueno SM, Bull P, Nathenson SG, Kalergis AM: The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge. Immunology 121(2), 227-237 (2007). (Pubitemid 46663091)
9. Carreno LJ, Riquelme EM, Gonzalez PA et al.: T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC. Proc. Natl Acad. Sci. USA 107(1), 210-215 (2010).
10. Coombs D, Kalergis AM, Nathenson SG, Wofsy C, Goldstein B: Activated TCRs remain marked for internalization after dissociation from pMHC. Nat. Immunol. 3(10), 926-931 (2002). (Pubitemid 35154005)
11. Gonzalez PA, Carreno LJ, Coombs D et al.: T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc. Natl Acad. Sci. USA 102(13), 4824-4829 (2005). (Pubitemid 40471538)
12. Kalergis AM, Boucheron N, Doucey MA et al.: Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2(3), 229-234 (2001). (Pubitemid 33705999)
13. Mcmahan RH, McWilliams JA, Jordan KR, Dow SW, Wilson DB, Slansky JE: Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J. Clin. Invest. 116(9), 2543-2551 (2006). (Pubitemid 44330153)
14. Ueno T, Tomiyama H, Fujiwara M, Oka S, Takiguchi M: Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J. Immunol. 173(9), 5451-5457 (2004). (Pubitemid 39392129)
15. Dustin ML: A dynamic view of the immunological synapse. Semin. Immunol. 17(6), 400-410 (2005). (Pubitemid 41654692)
16. Valitutti S, Dupre L: Plasticity of immunological synapses. Curr. Top Microbiol. Immunol. 340, 209-228 (2010).
17. Huse M, Lillemeier BF, Kuhns MS, Chen DS, Davis MM: T cells use two directionally distinct pathways for cytokine secretion. Nat. Immunol. 7(3), 247-255 (2006).
18. Maldonado RA, Irvine DJ, Schreiber R, Glimcher LH: A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431(7008), 527-532 (2004). (Pubitemid 39336325)
19. Lee SJ, Hori Y, Groves JT, Dustin ML, Chakraborty AK: Correlation of a dynamic model for immunological synapse formation with effector functions: two pathways to synapse formation. Trends Immunol. 23(10), 492-499. (2002). (Pubitemid 35248044)
20. Banchereau J, Briere F, Caux C et al.: Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000). (Pubitemid 30365397)
21. Bauer S, Muller T, Hamm S: Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653, 15-34 (2009).
22. Nimmerjahn F, Ravetch JV: Fc-receptors as regulators of immunity. Adv. Immunol. 96, 179-204 (2007). (Pubitemid 350018720)
23. Kalergis AM, Ravetch JV: Inducing tumor immunity through the selective engagement of activating Fcg receptors on dendritic cells. J. Exp. Med. 195(12), 1653-1659 (2002). (Pubitemid 34666079)
24. Kamradt T, Mitchison NA: Tolerance and autoimmunity. N. Engl. J. Med. 344(9), 655-664 (2001). (Pubitemid 32183582)
25. Iruretagoyena MI, Riedel CA, Leiva ED, Gutierrez MA, Jacobelli SH, Kalergis AM: Activating and inhibitory Fcg receptors can differentially modulate T cell-mediated autoimmunity. Eur J. Immunol. 38(8), 2241-2250 (2008).
26. Dhodapkar KM, Banerjee D, Connolly J et al.: Selective blockade of the inhibitory Fcg receptor (FcgRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med. 204(6), 1359-1369 (2007). (Pubitemid 46919874)
27. Bueno SM, Riedel CA, Carreno LJ, Kalergis AM: Virulence mechanisms displayed by Salmonella to impair dendritic cell function. Curr. Med. Chem. 17(12), 1156-1166 (2010).
28. Tobar JA, Carreno LJ, Bueno SM et al.: Virulent Salmonella enterica serovar Typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Infect. Immun. 74(11), 6438-6448 (2006). (Pubitemid 44657426)
29. Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flano E: Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J. Virol. 81(18), 9778-9789 (2007). (Pubitemid 350067682)
30. Bueno SM, Gonzalez PA, Carreno LJ et al.: The capacity of Salmonella to survive inside dendritic cells and prevent antigen presentation to T cells is host specific. Immunology 124(4), 522-533 (2008). (Pubitemid 351962548)
31. Gonzalez PA, Prado CE, Leiva ED et al.: Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc. Natl Acad. Sci. USA 105(39), 14999-15004 (2008).
32. Arhel N, Lehmann M, Clauss K, Nienhaus GU, Piguet V, Kirchhoff F: The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J. Clin. Invest. 119(10), 2965-2975 (2009).
33. Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A: Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24(5), 547-561 (2006). (Pubitemid 43728159)
34. Herrada AA, Contreras FJ, Tobar JA, Pacheco R, Kalergis AM: Immune complex-induced enhancement of bacterial antigen presentation requires Fcg receptor III expression on dendritic cells. Proc. Natl Acad. Sci. USA 104(33), 13402-13407 (2007). (Pubitemid 47293957)
35. Mozaffarian N, Wiedeman AE, Stevens AM: Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1. Rheumatology (Oxford) 47(9), 1335-1341 (2008).
36. Quadbeck B, Eckstein AK, Tews S et al.: Maturation of thyroidal dendritic cells in Graves' disease. Scand J. Immunol. 55(6), 612-620 (2002). (Pubitemid 34535554)
37. Clynes R, Dumitru C, Ravetch JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279(5353), 1052-1054 (1998). (Pubitemid 28113310)
38. Kalergis AM, Iruretagoyena MI, Barrientos MJ et al.: Modulation of nuclear factor-kB activity can influence the susceptibility to systemic lupus erythematosus. Immunology 128(1 Suppl.), e306-e314 (2009).
39. Carreno LJ, Pacheco R, Gutierrez MA, Jacobelli S, Kalergis AM: Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc g receptors and costimulatory molecules on dendritic cells. Immunology 128(3), 334-341 (2009).
40. Adorini L, Penna G: Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb. Exp. Pharmacol. (188), 251-273 (2009).
41. Buckland M, Lombardi G: Aspirin and the induction of tolerance by dendritic cells. Handb. Exp. Pharmacol. (188), 197-213 (2009).
42. Iruretagoyena MI, Sepulveda SE, Lezana JP et al.: Inhibition of nuclear factor-kB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis. J. Pharmacol. Exp. Ther. 318(1), 59-67 (2006).
43. Zanetti M, Castiglioni P, Schoenberger S, Gerloni M: The role of relB in regulating the adaptive immune response. Ann. NY Acad. Sci. 987, 249-257 (2003). (Pubitemid 36584030)
44. Saccani S, Pantano S, Natoli G: Modulation of NF-kB activity by exchange of dimers. Mol. Cell 11(6), 1563-1574 (2003). (Pubitemid 36776542)
45. Iruretagoyena MI, Tobar JA, Gonzalez PA et al.: Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J. Pharmacol. Exp. Ther. 312(1), 366-372 (2005). (Pubitemid 40096490)